-
1.发明申请公开(公告)号：US20140031337A1
公开(公告)日：2014-01-30
申请号：US14041665
申请日：2013-09-30
Applicant: Bristol-Myers Squibb Company
IPC: C07D487/04 , A61K31/541 , A61K31/53
CPC classification number: C07D487/04 , A61K31/53 , A61K31/541
Abstract: The present application provides compounds that are useful as MCHR1 antagonists, especially for the treatment of obesity, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I wherein the variables are defined herein.
Abstract translation: 本申请提供了可用作MCHR1拮抗剂的化合物，特别是用于治疗肥胖症，包括根据式I的所有立体异构体，溶剂合物，前药和药学上可接受的形式，其中变量在本文中定义。
-
Patent Agency Ranking
2.发明申请PYRROLONE OR PYRROLIDINONE MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS 有权吡咯酮或吡咯烷酮富含浓度的激素受体-1拮抗剂公开(公告)号：US20150218093A1
公开(公告)日：2015-08-06
申请号：US14425507
申请日：2013-09-03
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Saleem Ahmad , Guohua Zhao , William N. Washburn
IPC: C07D207/273 , C07D207/327 , C07D409/12 , C07D401/12
CPC classification number: C07D207/273 , C07D207/27 , C07D207/327 , C07D401/12 , C07D403/12 , C07D409/12
Abstract: The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are melanin concentrating hormone receptor-1 (MCHR1) antagonists which may be used as medicaments.
Abstract translation: 本发明提供式（I）化合物：如说明书中所定义和包含任何这些新化合物的组合物。 这些化合物是可用作药物的黑色素浓缩激素受体-1（MCHR1）拮抗剂。
-
公开(公告)号：US20150218092A1
公开(公告)日：2015-08-06
申请号：US14425165
申请日：2013-09-03
Applicant: Bristol-Myers Squibb Company
IPC: C07D207/273 , C07D403/12 , C07D403/14 , C07D405/12 , C07D491/107 , C07D401/12
CPC classification number: C07D207/273 , A61K31/4025 , A61K31/4178 , A61K31/422 , A61K31/435 , A61K31/445 , A61K31/496 , A61K31/506 , A61K31/5377 , C07D295/096 , C07D295/135 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/12 , C07D413/12 , C07D417/12 , C07D491/10 , C07D491/107
Abstract: The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are melanin concentrating hormone receptor-1 (MCHR1) antagonists which may be used as medicaments.
-
公开(公告)号：US08754211B2
公开(公告)日：2014-06-17
申请号：US14041665
申请日：2013-09-30
Applicant: Bristol-Myers Squibb Company
Inventor： Pratik Devasthale , William N. Washburn , Kishore V. Renduchintala , Radhakrishnan Sridhar
IPC: C07D487/04 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/14 , A61K31/4162 , A61K31/4188 , A61K31/53 , A61P3/04 , A61P3/10
CPC classification number: C07D487/04 , A61K31/53 , A61K31/541
Abstract: The present application provides compounds that are useful as MCHR1 antagonists, especially for the treatment of obesity, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I wherein the variables are defined herein.
Abstract translation: 本申请提供了可用作MCHR1拮抗剂的化合物，特别是用于治疗肥胖症，包括根据式I的所有立体异构体，溶剂合物，前药和药学上可接受的形式，其中变量在本文中定义。
-
5.发明授权Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists 有权吡咯酮或吡咯烷酮黑色素浓缩激素受体-1拮抗剂公开(公告)号：US09586900B2
公开(公告)日：2017-03-07
申请号：US14425507
申请日：2013-09-03
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Saleem Ahmad , Guohua Zhao , William N. Washburn
IPC: C07D207/273 , C07D207/327 , C07D401/12 , C07D409/12 , A61K31/4015 , A61K31/4025 , A61K31/4439 , C07D403/12 , C07D207/27
CPC classification number: C07D207/273 , C07D207/27 , C07D207/327 , C07D401/12 , C07D403/12 , C07D409/12
Abstract: The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are melanin concentrating hormone receptor-1 (MCHR1) antagonists which may be used as medicaments.
Abstract translation: 本发明提供式（I）化合物：如说明书中所定义和包含任何这些新化合物的组合物。 这些化合物是可用作药物的黑色素浓缩激素受体-1（MCHR1）拮抗剂。
-
6.发明授权Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists 有权吡咯酮或吡咯烷酮黑色素浓缩激素受体-1拮抗剂公开(公告)号：US09499482B2
公开(公告)日：2016-11-22
申请号：US14425165
申请日：2013-09-03
Applicant: BRISTOL-MYERS SQUIBB COMPANY
IPC: A61K31/5377 , A61K31/4025 , A61K31/496 , A61K31/445 , A61K31/506 , A61K31/435 , A61K31/422 , A61K31/4178 , C07D207/273 , C07D403/12 , C07D401/14 , C07D401/12 , C07D403/14 , C07D405/12 , C07D413/12 , C07D417/12 , C07D491/10 , C07D295/096 , C07D295/135 , C07D491/107
CPC classification number: C07D207/273 , A61K31/4025 , A61K31/4178 , A61K31/422 , A61K31/435 , A61K31/445 , A61K31/496 , A61K31/506 , A61K31/5377 , C07D295/096 , C07D295/135 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/12 , C07D413/12 , C07D417/12 , C07D491/10 , C07D491/107
Abstract: The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are melanin concentrating hormone receptor-1 (MCHR1) antagonists which may be used as medicaments.
-
-
-
-
-
Search Results
6
records
(took 0.026 seconds)
